Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem, Agilent Settle Patent Infringement Lawsuit

NEW YORK (GenomeWeb) – Agilent Technologies will pay Enzo Biochem $9 million to settle a patent infringement lawsuit between the companies, Enzo said today.

The suit alleged that Agilent had infringed on Enzo's U.S. Patent No. 7,064,197  for non-porous solid supports for fixed or immobilized nucleic acids. The legal action is more than a decade old — Enzo originally sued several companies, including PerkinElmer, Sigma-Aldrich, GE Healthcare, Affymetrix, Orchid Biosciences, Molecular Probes, and Roche, claiming the companies were infringing on eight different patents by selling certain reagent kits.

PerkinElmer settled with Enzo in June 2014 for $7 million, Siemens settled in July 2015 for an upfront payment of $9.5 million, Luminex settled in July 2015 for $7.1 million, and Affymetrix settled in October for $10 million.

In all, Enzo still has eight infringement cases pending before the court, the company said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.